BNP PARIBAS FINANCIAL MARKETS - PDS BIOTECHNOLOGY CORP ownership

PDS BIOTECHNOLOGY CORP's ticker is PDSB and the CUSIP is 70465T107. A total of 80 filers reported holding PDS BIOTECHNOLOGY CORP in Q2 2023. The put-call ratio across all filers is 0.90 and the average weighting 0.0%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of PDS BIOTECHNOLOGY CORP
ValueSharesWeighting
Q3 2023$88,804
+142.0%
17,585
+141.1%
0.00%
Q2 2023$36,694
-89.5%
7,295
-72.6%
0.00%
-100.0%
Q4 2022$351,014
+35001.4%
26,592
+1329500.0%
0.00%
Q1 2020$1,000
-80.0%
20.0%0.00%
Q4 2019$5,000
-90.7%
2
-87.5%
0.00%
Q3 2019$54,000
-43.8%
160.0%0.00%
Q2 2019$96,000160.00%
Other shareholders
PDS BIOTECHNOLOGY CORP shareholders Q2 2023
NameSharesValueWeighting ↓
New Leaf Venture Partners, L.L.C. 117,242$428,0000.28%
INSPIRION WEALTH ADVISORS, LLC 313,669$1,145,0000.25%
ACT CAPITAL MANAGEMENT, LLC 12,000$44,0000.06%
Sofinnova Investments, Inc. 142,635$521,0000.04%
KNIGHTSBRIDGE ASSET MANAGEMENT, LLC 44,362$162,0000.03%
XTX Topco Ltd 21,085$77,0000.03%
Andesa Financial Management Inc. 12,500$46,0000.03%
Virtu Financial LLC 47,326$173,0000.02%
Minot Wealth Management LLC 10,000$37,0000.01%
HAP Trading, LLC 25,500$160,0000.01%
View complete list of PDS BIOTECHNOLOGY CORP shareholders